ID30485A - Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4 - Google Patents

Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4

Info

Publication number: ID30485A
Authority: ID; Indonesia
Prior art keywords: pyrimidine; amino; metylsulfonyl; methodsulfonyl; isoenzim
Prior art date: 1999-02-06

Application number

IDW00200101892A

Other languages

English (en)

Indonesian (id)

Inventor

Ali Raza

John Stuart Pears

Howard Gerard Hutchinson

Dennis Schneck

Takahiko Baba

Akira Touchi

Yoshitaka Yamaguchi

Original Assignee

Astrazeneca Ab

Shionogi & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-06

Filing date

2000-02-01

Publication date

2001-12-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27269637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID30485(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-02-06 Priority claimed from GBGB9902593.4A external-priority patent/GB9902593D0/en

1999-09-08 Priority claimed from GBGB9921063.5A external-priority patent/GB9921063D0/en

1999-09-08 Priority claimed from GBGB9921064.3A external-priority patent/GB9921064D0/en

2000-02-01 Application filed by Astrazeneca Ab, Shionogi & Co filed Critical Astrazeneca Ab

2001-12-13 Publication of ID30485A publication Critical patent/ID30485A/id

Links

CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 2
239000002253 acid Substances 0.000 title 1
239000000890 drug combination Substances 0.000 title 1
239000000463 material Substances 0.000 title 1
WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

IDW00200101892A 1999-02-06 2000-02-01 Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4 ID30485A (id)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9902593.4A GB9902593D0 (en)	1999-02-06	1999-02-06	Drug combinations
GBGB9921063.5A GB9921063D0 (en)	1999-09-08	1999-09-08	Therapy
GBGB9921064.3A GB9921064D0 (en)	1999-09-08	1999-09-08	Drug combination

Publications (1)

Publication Number	Publication Date
ID30485A true ID30485A (id)	2001-12-13

Family

ID=27269637

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101892A ID30485A (id)	1999-02-06	2000-02-01	Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4

Country Status (28)

Country	Link
US (3)	US6982157B1 (pl)
EP (1)	EP1185274B1 (pl)
JP (2)	JP2002536331A (pl)
KR (2)	KR20010101790A (pl)
CN (1)	CN1165310C (pl)
AR (1)	AR029333A1 (pl)
AT (1)	ATE282415T1 (pl)
AU (1)	AU767304B2 (pl)
BR (1)	BR0007999A (pl)
CA (1)	CA2358632C (pl)
CZ (1)	CZ301296B6 (pl)
DE (1)	DE60015965T2 (pl)
EE (1)	EE04929B1 (pl)
EG (1)	EG23858A (pl)
ES (1)	ES2232418T3 (pl)
GB (1)	GB0000710D0 (pl)
ID (1)	ID30485A (pl)
IL (1)	IL144715A0 (pl)
IS (1)	IS2337B (pl)
MX (1)	MXPA01007905A (pl)
MY (1)	MY130606A (pl)
NO (1)	NO320745B1 (pl)
NZ (1)	NZ512982A (pl)
PL (1)	PL198034B1 (pl)
PT (1)	PT1185274E (pl)
TR (1)	TR200102228T2 (pl)
TW (1)	TWI282738B (pl)
WO (1)	WO2000045817A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
DE19944803A1 (de) *	1999-09-20	2001-03-29	Bayer Ag	Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
GB0003305D0 (en)	2000-02-15	2000-04-05	Zeneca Ltd	Pyrimidine derivatives
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
HU230253B1 (hu)	2001-01-26	2015-11-30	Merck Sharp & Dohme Corp	Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
DK1355644T3 (da)	2001-01-26	2006-10-23	Schering Corp	Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja)	2001-09-21	2005-02-10	シェーリング　コーポレイション	ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
WO2004043457A1 (en)	2002-11-06	2004-05-27	Schering Corporation	Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
CA2517571C (en)	2003-03-07	2011-07-05	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja)	2003-03-07	2010-12-01	シェーリングコーポレイション	高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
JP2006519869A (ja)	2003-03-07	2006-08-31	シェーリング　コーポレイション	置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
US9173847B2 (en)	2003-10-10	2015-11-03	Veloxis Pharmaceuticals A/S	Tablet comprising a fibrate
CA2540984C (en)	2003-10-10	2011-02-08	Lifecycle Pharma A/S	A solid dosage form comprising a fibrate
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2008509154A (ja)	2004-08-06	2008-03-27	トランスフオーム・フアーマシユーチカルズ・インコーポレーテツド	新規なスタチン薬剤組成物および関連治療方法
WO2007005941A2 (en)	2005-07-05	2007-01-11	President And Fellows Of Harvard College	Liver targeted conjugates
WO2007071357A2 (en)	2005-12-20	2007-06-28	Lek Pharmaceuticals D.D.	Pharmaceutical composition comprising (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5 -yl- (3r, 5s) -3, 5-dihydr0xyhept-6-en0ic acid
US20080109252A1 (en) *	2006-11-08	2008-05-08	Lafountain Andrea	Predicting patient compliance with medical treatment
US20120130202A1 (en) *	2010-11-24	2012-05-24	Fujitsu Limited	Diagnosis and Monitoring of Musculoskeletal Pathologies
WO2019241519A1 (en) *	2018-06-14	2019-12-19	Astrazeneca Uk Limited	Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
BR112022001514A2 (pt) *	2019-07-31	2022-03-22	Intas Pharmaceuticals Ltd	Composição farmacêutica multicamada e processo para a preparação de uma composição farmacêutica
WO2024223797A1 (en)	2023-04-28	2024-10-31	Institut National de la Santé et de la Recherche Médicale	Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2627696B1 (fr) *	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
JP2648897B2 (ja) *	1991-07-01	1997-09-03	塩野義製薬株式会社	ピリミジン誘導体
ATE114286T1 (de) *	1991-07-02	1994-12-15	Benckiser Gmbh Joh A	Zusammenfaltbare vorratsflasche.
JP3852621B2 (ja) *	1992-01-21	2006-12-06	あすか製薬株式会社	血管内皮細胞機能改善剤
FR2730231B1 (fr) *	1995-02-02	1997-04-04	Fournier Sca Lab	Association de fenofibrate et de vitamine e, utilisation en therapeutique
EP1027045A4 (en) *	1997-10-31	2004-12-08	Arch Dev Corp	METHODS AND COMPILATIONS FOR REGULATING S-ALPHA REDUCTASE ACTIVITY

2000
- 2000-01-14 GB GBGB0000710.4A patent/GB0000710D0/en not_active Ceased
- 2000-02-01 DE DE60015965T patent/DE60015965T2/de not_active Expired - Lifetime
- 2000-02-01 AT AT00901264T patent/ATE282415T1/de active
- 2000-02-01 CZ CZ20012844A patent/CZ301296B6/cs not_active IP Right Cessation
- 2000-02-01 KR KR1020017009914A patent/KR20010101790A/ko not_active Ceased
- 2000-02-01 PL PL364780A patent/PL198034B1/pl unknown
- 2000-02-01 KR KR1020067021986A patent/KR20060117381A/ko not_active Ceased
- 2000-02-01 EP EP00901264A patent/EP1185274B1/en not_active Expired - Lifetime
- 2000-02-01 ID IDW00200101892A patent/ID30485A/id unknown
- 2000-02-01 TR TR2001/02228T patent/TR200102228T2/xx unknown
- 2000-02-01 CN CNB008034702A patent/CN1165310C/zh not_active Expired - Lifetime
- 2000-02-01 ES ES00901264T patent/ES2232418T3/es not_active Expired - Lifetime
- 2000-02-01 AU AU21218/00A patent/AU767304B2/en not_active Expired
- 2000-02-01 CA CA002358632A patent/CA2358632C/en not_active Expired - Fee Related
- 2000-02-01 IL IL14471500A patent/IL144715A0/xx not_active IP Right Cessation
- 2000-02-01 NZ NZ512982A patent/NZ512982A/en not_active IP Right Cessation
- 2000-02-01 MX MXPA01007905A patent/MXPA01007905A/es not_active IP Right Cessation
- 2000-02-01 PT PT00901264T patent/PT1185274E/pt unknown
- 2000-02-01 EE EEP200100406A patent/EE04929B1/xx unknown
- 2000-02-01 JP JP2000596937A patent/JP2002536331A/ja active Pending
- 2000-02-01 US US09/889,414 patent/US6982157B1/en not_active Expired - Lifetime
- 2000-02-01 WO PCT/GB2000/000278 patent/WO2000045817A1/en not_active Ceased
- 2000-02-01 BR BR0007999-5A patent/BR0007999A/pt not_active Application Discontinuation
- 2000-02-04 MY MYPI20000416A patent/MY130606A/en unknown
- 2000-02-04 AR ARP000100507A patent/AR029333A1/es unknown
- 2000-02-22 EG EG20000124A patent/EG23858A/xx active
- 2000-05-11 TW TW089102105A patent/TWI282738B/zh not_active IP Right Cessation
2001
- 2001-07-17 IS IS6009A patent/IS2337B/is unknown
- 2001-08-03 NO NO20013811A patent/NO320745B1/no not_active IP Right Cessation
2005
- 2005-03-15 US US11/079,530 patent/US20060040969A1/en not_active Abandoned
2007
- 2007-07-27 JP JP2007195798A patent/JP2007277267A/ja active Pending
2008
- 2008-09-29 US US12/285,117 patent/US20090042911A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1185274E (pt)	2005-03-31
US20060040969A1 (en)	2006-02-23
WO2000045817A1 (en)	2000-08-10
IL144715A0 (en)	2002-06-30
US20090042911A1 (en)	2009-02-12
CZ301296B6 (cs)	2010-01-06
EE04929B1 (et)	2007-12-17
US6982157B1 (en)	2006-01-03
JP2002536331A (ja)	2002-10-29
NZ512982A (en)	2003-08-29
NO20013811D0 (no)	2001-08-03
IS2337B (is)	2008-02-15
EP1185274A1 (en)	2002-03-13
TWI282738B (en)	2007-06-21
BR0007999A (pt)	2001-11-06
ATE282415T1 (de)	2004-12-15
DE60015965T2 (de)	2006-01-05
ES2232418T3 (es)	2005-06-01
NO320745B1 (no)	2006-01-23
AU2121800A (en)	2000-08-25
CN1338936A (zh)	2002-03-06
KR20010101790A (ko)	2001-11-14
NO20013811L (no)	2001-10-02
IS6009A (is)	2001-07-17
EG23858A (en)	2007-11-18
AU767304B2 (en)	2003-11-06
EE200100406A (et)	2002-10-15
GB0000710D0 (en)	2000-03-08
PL198034B1 (pl)	2008-05-30
PL364780A1 (pl)	2004-12-13
CN1165310C (zh)	2004-09-08
DE60015965D1 (de)	2004-12-23
KR20060117381A (ko)	2006-11-16
CA2358632C (en)	2008-10-28
MY130606A (en)	2007-07-31
AR029333A1 (es)	2003-06-25
TR200102228T2 (tr)	2002-03-21
CA2358632A1 (en)	2000-08-10
CZ20012844A3 (cs)	2001-11-14
JP2007277267A (ja)	2007-10-25
EP1185274B1 (en)	2004-11-17
MXPA01007905A (es)	2003-06-04
HK1041817A1 (en)	2002-07-26

Publication	Publication Date	Title
ID30485A (id)	2001-12-13	Kombinasi obat yang terdiri dari ( e ) 7 [ 4 ( 4 fluorofenil ) 6 isopropil 2 [ metil (metilsulfonil) - amino ] pirimidin 5 il ] (3r,5s) 3,5 dihidroksihept-6- asam enoik dan suatu penghambat, bahat penginduksi atau bahan dari p450 isoenzim 3a4
FR2811552B1 (fr)	2002-12-27	Composition notamment cosmetique ou pharmaceutique se presentant sous forme solide
AU3569800A (en)	2000-10-23	Pyrimidine compounds with pharmaceutical activity
DE59812907D1 (de)	2005-08-11	Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
HUP0004310A3 (en)	2001-11-28	Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
AU1979501A (en)	2001-07-09	Optically active materials
AU3813499A (en)	1999-11-08	The use of dihydropyrimidines as medicaments, and novel substances
IL163552A (en)	2010-11-30	Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
AU3157801A (en)	2001-07-09	Beta-amino acid compounds as integrin antagonists
BR9807814B1 (pt)	2009-01-13	composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
AU2003252299A1 (en)	2004-02-16	Novel physiologically active substance
PT1169460E (pt)	2006-07-31	Preparacao de moleculas biologicamente activas.
AU5210798A (en)	1998-07-23	Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use
BR0014465B1 (pt)	2011-12-27	1,1'-bifenil-2-carbonamidas 2'-substituÍdas, preparado farmacÊutico e aplicaÇÕes dos referidos compostos.
DZ3155A1 (fr)	2000-11-02	Nouvelle composition pharmaceutique.
AU2759800A (en)	2000-09-04	Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils
AU2002238855A1 (en)	2003-03-20	N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU5073400A (en)	2000-12-18	Sulfonamide compounds with pharmaceutical activity
DE50305374D1 (de)	2006-11-23	Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
ZA200201521B (en)	2003-05-22	Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same.
AU5404800A (en)	2001-01-02	Process for the preparation of optically active n-acyl derivatives of methyl n-(2,6-dimethylphenyl)-d-alaninate
HUP0203275A3 (en)	2003-11-28	1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants
CA2379314A1 (en)	2001-01-25	Tablet for sucking, containing ambroxol
EP1369479A4 (en)	2004-12-08	Novel cell adhesion molecule specific to activated leukocyte
DZ3163A1 (fr)	2000-10-26	Nouvelle substance pharmaceutique.